{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:40Z","timestamp":1790610760664,"version":"4.1.0"},"reference-count":37,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PROCIENCIA-CONCYTEC-Peru","award":["018-2019"],"award-info":[{"award-number":["018-2019"]}]},{"DOI":"10.13039\/100020907","name":"Instituto Nacional de Salud","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020907","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Background. Peru ranks among the countries with the highest burden of tuberculosis in Latin America. Interferon Gamma Release Assays (IGRAs), such as QuantiFERON-TB (QFT), cannot distinguish latent tuberculosis infection (LTBI) from active tuberculosis (ATB), but they provide a more specific and quantitative assessment of prior exposure to Mycobacterium tuberculosis. Methods. We enrolled 56 participants and measured 38 cytokines\/chemokines from plasma obtained through QFT in patients with active TB (n = 11), LTBI (n = 17), and QFT-negative healthy controls (n = 28) using a Multiplex Bead Assay. Results. Levels of IL-1RA, IL-2, IL-5, IFN-\u03b3, and IP-10 significantly differentiated both ATB and LTBI groups from healthy controls (p &lt; 0.035). Furthermore, IL-5 and IP-10 specifically distinguished LTBI from healthy controls (p &lt; 0.015), while GM-CSF differentiated ATB from controls (p &lt; 0.05). Conclusions. Beyond IFN-\u03b3 as a differential proinflammatory cytokine in TB, cytokines such as IL-5, and IP-10 show potential as biomarkers to discriminate infection status in high-burden TB settings.<\/jats:p>","DOI":"10.3390\/pathogens14121225","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T09:34:37Z","timestamp":1764581677000},"page":"1225","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru"],"prefix":"10.3390","volume":"14","author":[{"given":"Nawal","family":"De la Pe\u00f1a Galindo","sequence":"first","affiliation":[{"name":"Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Capristano","family":"Valdez","sequence":"additional","affiliation":[{"name":"Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar Sanchez","family":"Neira","sequence":"additional","affiliation":[{"name":"Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri Bailon","family":"Calderon","sequence":"additional","affiliation":[{"name":"Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilmer Solis","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Health Technology Assessment Center, Instituto Nacional de Salud, Lima 15046, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor Peceros","family":"Pelaez","sequence":"additional","affiliation":[{"name":"Virology Unit, Instituto Nacional de Salud, Lima 15046, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6547-2354","authenticated-orcid":false,"given":"Marco","family":"Galarza Perez","sequence":"additional","affiliation":[{"name":"Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,30]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, September 15). Global Tuberculosis Report [Internet]. Available online: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"ref_2","first-page":"125","article-title":"Prevalencia de tuberculosis latente en estudiantes de medicina","volume":"31","year":"2018","journal-title":"Rev. Soc. Peru Med. Interna"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.17843\/rpmesp.2017.344.3337","article-title":"Prevalencia de infecci\u00f3n tuberculosa latente en trabajadores de salud de establecimientos del primer nivel de atenci\u00f3n. Lima, Per\u00fa","volume":"34","author":"Moore","year":"2017","journal-title":"Rev. Peru Med. Exp. Salud Publica"},{"key":"ref_4","unstructured":"Jilani, T.N., Avula, A., Zafar Gondal, A., and Siddiqui, A.H. (2025, June 26). Active Tuberculosis, StatPearls, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513246\/."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Carranza, C., Pedraza-Sanchez, S., de Oyarzabal-Mendez, E., and Torres, M. (2020). Diagnosis for Latent Tuberculosis Infection: New Alternatives. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02006"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4046\/trd.2016.79.4.201","article-title":"Tuberculosis Infection and Latent Tuberculosis","volume":"79","author":"Lee","year":"2016","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14737159.6.3.413","article-title":"New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis","volume":"6","author":"Pai","year":"2006","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_8","unstructured":"CDC Tuberculosis (TB) (2025, June 24). Clinical Testing Guidance for Tuberculosis: Interferon Gamma Release Assay, Available online: https:\/\/www.cdc.gov\/tb\/hcp\/testing-diagnosis\/interferon-gamma-release-assay.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: Latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_10","first-page":"250","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberc. Edinb. Scotl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tube.2016.06.001","article-title":"Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection","volume":"102","author":"Wu","year":"2017","journal-title":"Tuberculosis"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Biraro, I.A., Egesa, M., Kimuda, S., Smith, S.G., Toulza, F., Levin, J., Joloba, M., Katamba, A., Cose, S., and Dockrell, H.M. (2015). Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: An open label randomised, controlled, exploratory study. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1201-8"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chegou, N.N., Black, G.F., Kidd, M., van Helden, P.D., and Walzl, G. (2009). Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: Preliminary report. BMC Pulm. Med., 9.","DOI":"10.1186\/1471-2466-9-21"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chegou, N.N., Detjen, A.K., Thiart, L., Walters, E., Mandalakas, A.M., Hesseling, A.C., and Walzl, G. (2013). Utility of Host Markers Detected in Quantiferon Supernatants for the Diagnosis of Tuberculosis in Children in a High-Burden Setting. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064226"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wergeland, I., Assmus, J., and Dyrhol-Riise, A.M. (2016). Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163848"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Suzukawa, M., Akashi, S., Nagai, H., Nagase, H., Nakamura, H., Matsui, H., Hebisawa, A., and Ohta, K. (2016). Combined Analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0152483"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","article-title":"Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease","volume":"74","author":"Won","year":"2017","journal-title":"J. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tube.2017.07.013","article-title":"Multiplex analysis of plasma cytokines\/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants","volume":"107","author":"Yao","year":"2017","journal-title":"Tuberculosis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/IAI.00759-17","article-title":"Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia","volume":"86","author":"Teklu","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhang, L., Yang, Z., Wu, F., Ge, Q., Zhang, Y., Li, D., Gao, M., and Liu, X. (2024). Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: An exploratory study. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-023-08943-0"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1129398","DOI":"10.3389\/fimmu.2023.1129398","article-title":"Cytokine\/chemokine profiles in people with recent infection by Mycobacterium tuberculosis","volume":"14","author":"Herrera","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11481","DOI":"10.1038\/s41598-023-38372-7","article-title":"Identification of immune biomarkers in recent active pulmonary tuberculosis","volume":"13","author":"Shaukat","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.2147\/IDR.S470963","article-title":"Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates Mycobacterium tuberculosis Infection Status: An Exploratory Study","volume":"17","author":"Li","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e855","DOI":"10.1016\/j.ijid.2012.07.013","article-title":"Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis","volume":"16","author":"Hong","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Marczewska, A., Wojciechowska, C., Marczewski, K., Gospodarczyk, N., Dolibog, P., Czuba, Z., Wr\u00f3bel, K., and Zalejska-Fiolka, J. (2025). Elevated Levels of IL\u20131Ra, IL\u20131\u03b2, and Oxidative Stress in COVID-19: Implications for Inflammatory Pathogenesis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14072489"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"483578","DOI":"10.1155\/2014\/483578","article-title":"Flt3\/Flt3L Participates in the Process of Regulating Dendritic Cells and Regulatory T Cells in DSS-Induced Colitis","volume":"2014","author":"Mao","year":"2014","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mishra, A., Singh, V.K., Actor, J.K., Hunter, R.L., Jagannath, C., Subbian, S., and Khan, A. (2020). GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01599"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wei, Z., Li, Y., Wei, C., Li, Y., Xu, H., Wu, Y., Jia, Y., Guo, R., Jia, J., and Qi, X. (2020). The meta-analysis for ideal cytokines to distinguish the latent and active TB infection. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-01280-x"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.smim.2014.09.011","article-title":"Pro- and anti-inflammatory cytokines in tuberculosis: A two-edged sword in TB pathogenesis","volume":"26","author":"Etna","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pandiarajan, A.N., Kumar, N.P., Selvaraj, N., Ahamed, S.F., Viswanathan, V., Thiruvengadam, K., Hissar, S., Shanmugam, S., Bethunaickan, R., and Nott, S. (2024). Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1392256"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/infdis\/jiae365","article-title":"Plasma Immune Biomarkers Predictive of Progression to Active Tuberculosis in Household Contacts of Patients With Tuberculosis","volume":"231","author":"Rajamanickam","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2014.12.019","article-title":"IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy","volume":"70","author":"Wergeland","year":"2015","journal-title":"J. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rapulana, A.M., Mpotje, T., Baiyegunhi, O.O., Ndlovu, H., Smit, T.K., McHugh, T.D., and Marakalala, M.J. (2024). Combined analysis of host IFN-\u03b3, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6\/CFP10 stimulated blood. Front. Mol. Med., 4.","DOI":"10.3389\/fmmed.2024.1345510"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/infdis\/jiae642","article-title":"Predictive Markers of Incident Tuberculosis in Close Contacts in Brazil and India","volume":"232","author":"Nogueira","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107915","DOI":"10.1016\/j.ijid.2025.107915","article-title":"QuantiFERON-TB supernatant-based biomarkers predicting active tuberculosis progression","volume":"157","author":"Xu","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sanchez, C., Jaramillo-Valverde, L., Capristano, S., Solis, G., Soto, A., Valdivia-Silva, J., Poterico, J.A., and Guio, H. (2023). Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis Infection. Microorganisms, 11.","DOI":"10.3390\/microorganisms11061385"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7856347","DOI":"10.1155\/2021\/7856347","article-title":"Tuberculosis among Migrant Populations in Sicily: A Field Report","volume":"2021","author":"Prestileo","year":"2021","journal-title":"J. Trop. Med."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/12\/1225\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:22:50Z","timestamp":1764652970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/12\/1225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,30]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["pathogens14121225"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14121225","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,30]]}}}